Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Triller Group (NASDAQ:ILLR) Penny Stock: Debt Crisis Overshadows Brand Value

Triller Group Inc. (NASDAQ: ILLR) is a technology and media company best known for the Triller short-video platform, which became publicly traded through a merger with a financial-services company. The combined business now spans social media and Hong Kong-based financial services. Despite a recognisable …

Nitish Kishor | 11 June 2026

Werewolf Therapeutics (NASDAQ:HOWL): Can Cancer Data Attract a Strategic Partner?

Werewolf Therapeutics, Inc. (NASDAQ: HOWL) is a clinical-stage immuno-oncology company developing conditionally activated therapies designed to unleash the immune system against cancer while limiting toxicity. Its science is genuinely interesting, with early clinical signals in difficult cancers, but the company now trades below $1 …

Nitish Kishor | 11 June 2026

Hyperscale Data (NYSE American:GPUS): A Penny Stock Between AI Infrastructure and Bitcoin

Hyperscale Data, Inc. (NYSE American: GPUS) is a diversified holding company that has repositioned itself around two of the hottest themes in markets: artificial-intelligence data centres and a Bitcoin treasury strategy. Operating through subsidiaries, it owns data-centre capacity, mines and holds Bitcoin, and has …

Nitish Kishor | 11 June 2026

Gossamer Bio (NASDAQ:GOSS): A Penny Stock Trading Below Cash After Trial Setback

Gossamer Bio, Inc. (NASDAQ: GOSS) is a clinical-stage biopharmaceutical company that has become a closely watched, binary-outcome name among speculative biotech investors. Its fortunes are tied largely to a single asset, seralutinib, a treatment in development for pulmonary arterial hypertension. With shares trading well …

Nitish Kishor | 11 June 2026

GoHealth (NASDAQ:GOCO): A Penny Stock Facing Bankruptcy and Delisting Risk

GoHealth, Inc. (NASDAQ: GOCO) is a health-insurance marketplace company that has become one of the starkest cautionary tales in the penny-stock landscape. Once a higher-profile player in Medicare insurance distribution, the company has entered a prepackaged Chapter 11 restructuring designed to transfer ownership to …

Nitish Kishor | 11 June 2026

Genius Group (NYSE American:GNS): A Penny Stock Between AI Learning and Bitcoin

Genius Group Limited (NYSE American: GNS) is an education-technology company that has become unusually well known among speculative investors for two very different reasons: an ambitious AI-driven education business and a high-profile Bitcoin treasury strategy wrapped in ongoing litigation. Few small-cap companies combine a …

Nitish Kishor | 11 June 2026

GD Culture Group (NASDAQ:GDC): A Penny Stock Caught Between AI and Crypto

GD Culture Group Limited (NASDAQ: GDC) is a small holding company that blends several speculative themes: artificial-intelligence applications, live-streaming e-commerce on social platforms such as TikTok, and a planned cryptocurrency-treasury strategy. With shares trading around a dime and a small market capitalisation, GDC is …

Nitish Kishor | 11 June 2026

Faraday Future (NASDAQ:FFAI): EV Penny Stock Chasing an AI Robotics Pivot

Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) is one of the most heavily watched names in the US electric-vehicle penny-stock universe. Few companies generate the mix of ambition, controversy and volatility that Faraday Future does. The company has spent years promising a luxury electric …

Nitish Kishor | 11 June 2026

Ensysce Biosciences (NASDAQ:ENSC): A Penny Stock Testing the Future of Safer Opioids

Ensysce Biosciences, Inc. (NASDAQ: ENSC) is a clinical-stage pharmaceutical company developing abuse-deterrent and overdose-protected opioids using proprietary chemistry technologies. Its work targets the serious public-health problem of opioid abuse and overdose, and its lead program has received an FDA Breakthrough Therapy designation. With shares …

Nitish Kishor | 11 June 2026

Penny Stock Watch: Can Beyond Air (NASDAQ:XAIR) Stock Recover as LungFit Revenue Grows?

Beyond Air, Inc. (NASDAQ: XAIR) is a commercial-stage medical-device company built around nitric oxide therapy, most notably its LungFit platform for respiratory conditions. Unlike many penny stocks that are purely pre-revenue, Beyond Air is generating growing product revenue and has an installed base of …

Nitish Kishor | 11 June 2026
Support

Hi! How can we help you today?

Loading…